New vaccine combats gastroenteritis

on the 26 May 2006

GlaxoSmithKline has launched Rotarix, a live attenuated rotavirus vaccine, for the prevention of gastroenteritis due to rotavirus infection.

Rotarix is an oral vaccine indicated for infants from the age of six weeks. The vaccination course consists of two oral doses. The first dose is administered to infants from the age of six weeks, with the second dose being given after an interval of at least four weeks.

The vaccination course should preferably be given before 16 weeks of age, but must be completed by the age of 24 weeks.

Rotarix is presented as a powder and solvent for oral suspension. The cost of a single dose is £41.38.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more